Skip to content
Independent analysis of NHS open data
PharmaInsight

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide vs Aciclovir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated January 2026

Aciclovir was dispensed 36,433.3× as often as Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide in January 2026 — 109,300 items versus 3 in England.

3items

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide · January 2026

NHSBSA Prescription Cost Analysis

109,300items

Aciclovir · January 2026

NHSBSA Prescription Cost Analysis

Figure 1. Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide versus Aciclovir: national items dispensed by month

▬ Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide   ·   ╌ Aciclovir

0 56k 112k Jan 2026 Aciclovir 3 Jan 2026: 3

Source: NHSBSA Prescription Cost Analysis, to January 2026

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide versus Aciclovir, January 2026
Measure Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide Aciclovir
Items, January 2026 3 109,300
Items, last 12 months 3 1,279,503
Net ingredient cost, January 2026 £88 £293,010

See the full profile for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide or Aciclovir.